45 min listen
Management of Localized Non-Small Cell Lung Cancer with EGFR Tumor Mutations with Dr Roy Herbst
Management of Localized Non-Small Cell Lung Cancer with EGFR Tumor Mutations with Dr Roy Herbst
ratings:
Length:
39 minutes
Released:
Apr 12, 2021
Format:
Podcast episode
Description
Dr Roy Herbst from the Yale Cancer Center discusses the clinical data on and optimal use of adjuvant osimertinib for patients with resected non-small cell lung cancer and an EGFR mutation.
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayEGFRNSCLC21).
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayEGFRNSCLC21).
Released:
Apr 12, 2021
Format:
Podcast episode
Titles in the series (100)
Oncology Today with Dr Neil Love: Small Cell Lung Cancer Edition: For this special edition of Oncology Today, I met with Dr Charles Rudin from Memorial Sloan Kettering Cancer Center in New York to discuss recently published and emerging research in the management of small cell lung cancer. by Oncology Today with Dr Neil Love